Furthermore, embryonal and alveolar rhabdomyosarcoma frequently have increased expression of PTCH1 and GLI1, transcriptional targets of the Hh signalling pathway, and increased Hh pathway activation is associated with rapid progression and poor outcomes [100]. The gene discussed is PTCH1; the disease is rhabdomyosarcoma.